Orion Oyj (HEL:ORNAV)
Finland · Delayed Price · Currency is EUR 68.90
-0.20 (-0.29%)
Jul 21, 2025, 6:29 PM EET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Sale of Goods | 1.14B | Log In | Log In | Log In | Log In | Upgrade |
Sale of Goods Growth | 10.30% | Log In | Log In | Log In | Log In | Upgrade |
Royalty Income | 271.00M | Log In | Log In | Log In | Log In | Upgrade |
Royalty Income Growth | 122.15% | Log In | Log In | Log In | Log In | Upgrade |
Milestone Payments | 133.80M | Log In | Log In | Log In | Log In | Upgrade |
Milestone Payments Growth | 289.44% | Log In | Log In | Log In | Log In | Upgrade |
Animal Health | 128.20M | Log In | Log In | Log In | Log In | Upgrade |
Animal Health Growth | 20.75% | Log In | Log In | Log In | Log In | Upgrade |
Fermion | 72.30M | Log In | Log In | Log In | Log In | Upgrade |
Fermion Growth | -9.18% | Log In | Log In | Log In | Log In | Upgrade |
Translation Differences and Other Operations | 800.00K | Log In | Log In | Log In | Log In | Upgrade |
Translation Differences and Other Operations Growth | 0% | Log In | Log In | Log In | Log In | Upgrade |
Innovative Medicines | 525.20M | Log In | Log In | Log In | Log In | Upgrade |
Innovative Medicines Growth | 125.57% | Log In | Log In | Log In | Log In | Upgrade |
Branded Products | 287.50M | Log In | Log In | Log In | Log In | Upgrade |
Branded Products Growth | 8.36% | Log In | Log In | Log In | Log In | Upgrade |
Generics and Consumer Health | 528.40M | Log In | Log In | Log In | Log In | Upgrade |
Generics and Consumer Health Growth | 2.86% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Finland | 347.40M | Log In | Log In | Log In | Log In | Upgrade |
Finland Growth | 3.34% | Log In | Log In | Log In | Log In | Upgrade |
Scandinavia | 163.10M | Log In | Log In | Log In | Log In | Upgrade |
Scandinavia Growth | 13.07% | Log In | Log In | Log In | Log In | Upgrade |
Other Europe | 431.30M | Log In | Log In | Log In | Log In | Upgrade |
Other Europe Growth | 20.48% | Log In | Log In | Log In | Log In | Upgrade |
North America | 368.70M | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | 101.44% | Log In | Log In | Log In | Log In | Upgrade |
Other Markets | 231.90M | Log In | Log In | Log In | Log In | Upgrade |
Other Markets Growth | 40.22% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2011 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2011 - 2018 |
Human Pharmaceuticals (Hospital and Pharmacy Channel) Reported Market Share | Log In | Log In | Log In | Log In | Upgrade |
Reference Priced Prescription Drugs (Pharmacy Channel) Reported Market Share | Log In | Log In | Log In | Log In | Upgrade |
Self-Care Products (Pharmacy Channel) Reported Market Share | Log In | Log In | Log In | Log In | Upgrade |
Prescription Drugs (Pharmacy Channel) Reported Market Share | Log In | Log In | Log In | Log In | Upgrade |